(Q51813912)

13 April 2018

http://europepmc.org/abstract/MED/16163060

title

Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog. (English)

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

0 references

2

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

Gabor Halmos

series ordinal

4

object named as

Gabor Halmos

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

Karoly Szepeshazi

series ordinal

1

object named as

Karoly Szepeshazi

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

author name string

Attila Nagy

series ordinal

3

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

publication date

1 October 2005

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

published in

Pancreas

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

volume

31

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

issue

3

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

page(s)

275-282

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

cites work

Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Cancer statistics, 2005

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Update on pancreatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu13-BN1).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Developments in the systemic therapy of pancreatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Adjuvant and neoadjuvant therapies of pancreatic cancer: a review

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Bombesin receptors in distinct tissue compartments of human pancreatic diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Gut peptide receptor expression in human pancreatic cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/01.MPA.0000175892.97036.A7

Identifiers

DOI

10.1097/01.MPA.0000175892.97036.A7

1 reference

13 April 2018

http://europepmc.org/abstract/MED/16163060

1 reference

13 April 2018